← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
National Development And Research Institutes, Inc.
New York, NY
$105,287,772
Total funding
99
Grants
Funding over time
peak $16.5M · FY2006–18$20M$15M$10M$5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$104,699,881 · 97
CDC$587,891 · 1
SAMHSA$0 · 1
By mechanism
R01$79,441,926 · 52
R21$5,752,695 · 16
U01$5,317,864 · 2
DP1$3,787,612 · 1
RC2$3,439,782 · 1
R34$2,946,710 · 6
Investigators at National Development And Research Institutes, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Largest grants
Computerized Psychosocial Treatment for Offenders with Substance Use Disorders$1,882,638
RC2 · FY2009 · DA
Computerized Psychosocial Treatment for Offenders with Substance Use Disorders$1,557,144
RC2 · FY2010 · DA
START Together: HIV Testing and Treatment in and after Jail$1,226,504
R01 · FY2010 · DA
High Risk Drug Use & HIV-Learning from the NYC Epidemic$978,265
P30 · FY2006 · DA
High Risk Drug Use & HIV-Learning from the NYC Epidemic$964,829
P30 · FY2007 · DA
An Interdisciplinary Approach to HIV and Other Infectious Diseases of Drug Users$931,499
P30 · FY2008 · DA
NDRI Colorado Research for CJDATS$917,769
U01 · FY2006 · DA
Peer-Driven Intervention to Enroll Minorities/Women in HIV/AIDS Clinical Trials$824,067
R01 · FY2009 · AI
Peer-Driven Intervention to Enroll Minorities/Women in HIV/AIDS Clinical Trials$803,751
R01 · FY2008 · AI
Overdose Risk Management and Compensation in the Era of Naloxone$796,321
R01 · FY2018 · DA
Preventing HIV Transmission by Recently-Infected Drug Users$767,500
DP1 · FY2014 · DA
Preventing HIV Transmission by Recently-Infected Drug Users$767,500
DP1 · FY2012 · DA
Web-based CBT for Substance Misusing and PTSD Symptomatic OEF/OIF Veterans$762,529
R01 · FY2010 · AA
The Staying Safe Intervention: Preventing HCV among Young Opioid Injectors$761,598
R01 · FY2016 · DA
Preventing HIV Transmission by Recently-Infected Drug Users$759,825
DP1 · FY2016 · DA
Preventing HIV Transmission by Recently-Infected Drug Users$755,987
DP1 · FY2015 · DA
The Staying Safe Intervention: Preventing HCV among Young Opioid Injectors$746,948
R01 · FY2017 · DA
The Staying Safe Intervention: Preventing HCV among Young Opioid Injectors$739,640
R01 · FY2018 · DA
Preventing HIV Transmission by Recently-Infected Drug Users$736,800
DP1 · FY2013 · DA
NDRI Colorado Research for CJDATS$736,435
U01 · FY2007 · DA